<DOC>
	<DOCNO>NCT02989155</DOCNO>
	<brief_summary>The purpose study determine need blood transfusion surgery evaluate level certain protein blood give tranexamic acid .</brief_summary>
	<brief_title>Tranexamic Acid Use Blood Loss Total Hip Arthroplasty</brief_title>
	<detailed_description>A review medical record January 01 2013 July 1st 2015 used determine hypothesis patient receive tranexamic acid lower need blood transfusion change level proteins essential healthy oxygen transport throughout body correct . Tranexamic acid medication may help wound stop bleed quickly . Participants expect receive direct benefit participate study . Only small risk private patient medical information expose anticipate . The result study help surgeon medical community well understand use type drug possible role benefit hip replacement patient follow surgery .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Adult patient 18 year age old Surgical patient underwent primary total hip arthroplasty ( THA ) Surgical patient underwent revision THA Preoperative hemoglobin value ( N ) 11 g/dl Normal international normalize ratio ( INR ) , prothrombin time ( PT ) , partial thromboplastin time ( PTT ) value Allergy tranexamic acid Bilateral THA History ischemic heart disease Severe chronic heart failure Hepatic dysfunction Chronic renal failure On hemodialysis Cerebral infarction History seizure Bleeding disorder Anticoagulant aspirinlike medication long act NSAID medication Short acting NSAID 's discontinue least 24 hr surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>